Omega Therapeutics Reports Second Quarter 2023 Financial
Continued Enrollment in Monotherapy Dose Escalation Stage of Phase 1/2 MYCHELANGELO™ I Study; Preliminary First-in-Human Safety, Tolerability,...
Source: globenewswire.com
Stay updated with breaking news from Translational Data Anticipated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Continued Enrollment in Monotherapy Dose Escalation Stage of Phase 1/2 MYCHELANGELO™ I Study; Preliminary First-in-Human Safety, Tolerability,...